Skip to content
value.today

Artisan Pharma, Inc.

🇺🇸 Waltham, Massachusetts, USABiotechnologyFounded 2006

Formerly ARTISAN THERAPEUTICS INC, NA Innovation Corporation

Total raised
$41 M
3 rounds on record
Latest round
$3 M
Jul 2010
First round on record
Apr 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Artisan Pharma, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2010$3 MNo. 3$2 to $10 million

Artisan Pharma, Inc.: Raise no. 3, Jul 2010

Investors in this round

8 investors had bought by the notice of Jul 20, 2010: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary D. Shearman · Executive Officer, Director
  • Georg D. Nebgen · Director
  • Hironori D. Hozoji · Director
  • John D. Costantino · Director
  • Minoru D. Takada · Director
  • Naoyuki D. Ono · Director
  • Thong-Yuen D. Poon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary Shearman, President. Source: SEC Form D, newest notice filed Jul 20, 2010. Read the notice at the SEC.

equitySEC
Feb 2010$22 MNo. 2$10 to $50 million

Artisan Pharma, Inc.: Raise no. 2, Feb 2010

Investors in this round

8 investors had bought by the notice of Mar 10, 2010: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary D. Shearman · Executive Officer, Director
  • Georg D. Nebgen · Director
  • Hironori D. Hozoji · Director
  • John D. Costantino · Director
  • Naoyuki D. Ono · Director
  • Thong-Yuen D. Poon · Director
  • Toshio D. Asano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary Shearman, Executive Chairman. Source: SEC Form D, newest notice filed Mar 10, 2010. Read the notice at the SEC.

equitySEC
Apr 2009$15 MNo. 1$10 to $50 million

Artisan Pharma, Inc.: Raise no. 1, Apr 2009

Investors in this round

13 investors had bought by the notice of Jan 20, 2010: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $18 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gary D. Shearman · Executive Officer, Director
  • Georg Yuen Nebgen · Director
  • Hironori D. Hozoji · Director
  • John Yuen Costantino · Director
  • Thong Yuen Poon · Director
  • Toshio Yuen Asano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary Shearman, Executive Chairman. Source: SEC Form D and 1 amendment, newest notice filed Jan 20, 2010. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Artisan Pharma, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2010).

    SEC Form D · Jul 2010

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2010

That is all the official record says: Artisan Pharma, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Artisan Pharma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Artisan Pharma, Inc.
NameRoleNamed in
Gary D. ShearmanExecutive officerJul 2010
Jeffrey D. WagerExecutive officerMay 2009
Gary D. ShearmanDirectorJul 2010
Georg D. NebgenDirectorJul 2010
Hironori D. HozojiDirectorJul 2010
John D. CostantinoDirectorJul 2010
Minoru D. TakadaDirectorJul 2010
Naoyuki D. OnoDirectorJul 2010
Thong-Yuen D. PoonDirectorJul 2010
Toshio D. AsanoDirectorMar 2010
Georg Yuen NebgenDirectorJan 2010
John Yuen CostantinoDirectorJan 2010
Thong Yuen PoonDirectorJan 2010
Toshio Yuen AsanoDirectorJan 2010
Gary ShearmanDirectorMay 2009
Georg NebgenDirectorMay 2009
Hironori HozojiDirectorMay 2009
Jeffrey D. WagerDirectorMay 2009
John CostantinoDirectorMay 2009
Philippe ChambonDirectorMay 2009
Toshio AsanoDirectorMay 2009